Antibodies
The hunt for neutralising antibodies against SARS-CoV-2
Scientists hope that a legacy of the novel coronavirus in recovered COVID-19 patients – antibodies in their blood – could lead to drugs to treat others. The Merten group at EMBL Heidelberg has pivoted its microfluidics platform to support the search for neutralising antibodies that could…
EMBL spinoff to help antibody discovery
New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies…
